Evidence map›Paper›PMID 28878188›Full record

ArticleMolecules (Basel, Switzerland)2017

MTLD, a Database of Multiple Target Ligands, the Updated Version.

Chao Chen, Meng Wu, Shan Cen, Jianhui Wu, Jinming Zhou

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chao ChenNorth China Institute of Science and Technology, Beijing 065201, China. angelstudio@gmail.com.
Meng WuInstitute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing 100050, China. wumeng_1915@163.com.
Shan CenInstitute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing 100050, China. shancen@hotmail.com.
Jianhui WuLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada. jian.h.wu@mcgill.ca.
Jinming ZhouInstitute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing 100050, China. zhoujinming@imb.pumc.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polypharmacology plays an important role in drug discovery and polypharmacology drug strategies provide a novel path in drug design. However, to develop a polypharmacology drug with the desired profile remains a challenge. Previously, we developed a free web-accessible database called Multiple Target Ligand Database (MTLD, www.mtdcadd.com). Herein, the MTLD database has been updated, containing 2444 Multiple Target Ligands (MTLs) that bind with 21,424 binding sites from 18,231 crystal structures. Of the MTLs, 304 entries are approved drugs, and 1911 entries are drug-like compounds. Also, we added new functions such as multiple conditional search and linkage visualization. Through querying the updated database, extremely useful information for the development of polypharmacology drugs may be provided.

Indexed as

Databases, PharmaceuticalDatabases, ProteinPolypharmacologyBinding SitesData MiningDrug DiscoveryHumansLigandsProtein BindingProteinsLigandsProteinsdatabasedrug discoveryMultiple Target Ligands (MTLs)polypharmacology

Identifiers

PMID28878188
PMCPMC6151691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.